Skip to main content

FOXO Technologies Inc.

corporate_fare Company Profile

FOXO Technologies Inc.

FOXOW·OTC·Industrial Applications And Services·CIK 0001812360

FOXO Technologies Inc. is a healthcare services and technology company operating four synergistic divisions: a rural hospital division, a mental and behavioral health division, an information, data and biospecimen sourcing division, and an epigenetics diagnostics and interpretation division. The company's mission is to build healthier communities by offering a diverse and adaptable range of healthcare services and solutions. FOXO Technologies Inc., formerly Delwinds Insurance Acquisition Corp., was originally formed in April 2020. Through acquisitions, the company offers behavioral health services, including substance use disorder treatment, and operates a critical access designated hospital in Oneida, Tennessee. It also serves as an information, data, and biospecimen sourcing provider for the biotechnology, clinical research, and pharmaceutical research industries. Additionally, FOXO is commercializing epigenetic biomarker technology for scientific research and next-generation business initiatives. The company manages its business through three reportable segments: Healthcare, Life Science Services, and Labs. Myrtle Recovery Centers, Inc. (acquired June 14, 2024), Rennova Community Health, Inc., and its subsidiary Scott County Community Health, Inc. (acquired September 10, 2024) operate under the Healthcare segment. Vector BioSource Inc. (acquired September 19, 2025) operates under the Life Science Services segment. The Labs segment was formed by combining the previously separate Labs and Life segments during the second quarter of 2024, following the acquisition of Myrtle in June 2024.

FOXO Technologies Inc. (OTC:FOXOW) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 2 items for FOXOW at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 8/10. Across its 2 most recent items scored 7 or higher, the top rating is 8/10, with 1 rated 8 or above. Recent SEC coverage for FOXOW spans 8-K, DEF 14C.

Recent high-impact activity:

  • FOXO to Buy ~71% of Ludwig Preferred, Gaining Majority Voting Control
  • FOXO Technologies Authorizes Reverse Split Up to 1:1,000 to Pursue Nasdaq/NYSE American Uplisting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$16.37M
Net Income
-$12.43M
Op. Cash Flow
-$3.87M
Free Cash Flow
-$3.93M
Operating Income
-$10.33M
Cash & Equivalents
$207.45K
Debt / Equity
0.00×
Net Margin
-75.9%
Source: 10-K · filed 2026-04-15 · accession 0001493152-26-016725

Short Interest & Short Volume

113.89 days to cover

FINRA reported short interest of 2,050 shares in FOXOW as of the October 30, 2026 settlement, unchanged from the prior period — about 113.9 days to cover at its recent average daily volume. On November 19, 2026, 40.0% of FOXOW volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,050 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover113.89 at avg daily volume of 18
Daily short volume (FINRA facilities)40.0% of 50,000 shares on November 19, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.002
52-week range · as of 2026-10-29 $0.0001 – $0.07
Market cap
$149.23K
Volume
100 (0.0× avg)
3-mo avg 28.3K
From SEC filing · 2026-10-29

show_chartPrice Chart

Loading chart...

feed FOXOW - Latest Insights

FOXOW
Oct 29, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
FOXOW
Aug 24, 2026, 5:17 PM EDT
Filing Type: DEF 14C
Importance Score:
7
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets